FDA Approved: SANCUSO — Supplemental Application (Cumberland Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved Cumberland Pharmaceuticals' supplemental application for SANCUSO (granisetron), the transdermal antiemetic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• SANCUSO (GRANISETRON)

Snippet

SUPPL AP for SANCUSO (GRANISETRON)